Main
>
ONCOLOGY (**)
>
Lymphoma>NHL>T-Cell>PTCL R/R *
>
Treatment
>
USA. S. Brand Pralatrexate Inj.
>
Patent>USA Expiration: 2025. 11.24.
Patent>USA Expiration: 2025. 11.24.'s products
This section has no products